MAOIF yields 6.29% · JNJ yields 2.13%● Live data
📍 MAOIF pulled ahead of the other in Year 1
Combined, MAOIF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of MAOIF + JNJ for your $10,000?
Manitou BF SA develops, manufactures, and provides equipment and services for the construction, agriculture, and industry sectors worldwide. It operates in two divisions, Product, and Services & Solutions. The company offers material handling, access, and earthmoving equipment, including rough-terrain fixed, rotating, and heavy-duty telehandlers; rough-terrain, semi-industrial, and industrial forklift trucks; wheeled or tracked skid-steer, articulated, and backhoe loaders; aerial work platforms; and truck-mounted forklifts, as well as warehousing equipment and attachments. It also provides attachments, such as buckets, clamps, fork handling solutions, forks and grapples, jibs, work platforms, skips, sweepers and cleaners, winches, mining accessories, and miscellaneous attachments, as well as backrest, carriage, and interface references. In addition, the company offers value added services comprising technical training, new or refurbished spare parts, after-sales service, machine connectivity, financing solutions, maintenance and warranty extension contracts, rent-to-rent leases, full-service contracts, recovery, repair, and resale of used equipment. The company offers its products through a network of dealers under the Manitou, Gehl, and Mustang by Manitou brands. Manitou BF SA was incorporated in 1954 and is headquartered in Ancenis, France.
Full MAOIF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.